Equities

Dr Reddy's Laboratories Ltd

Dr Reddy's Laboratories Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)14.37
  • Today's Change0.165 / 1.16%
  • Shares traded266.01k
  • 1 Year change+5.27%
  • Beta0.5380
Data delayed at least 15 minutes, as of Nov 25 2024 16:43 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income55,68445,06723,568
Depreciation/depletion14,84112,63611,824
Non-Cash items15,13719,74114,067
Cash taxes paid, supplemental20,04710,7147,437
Cash interest paid, supplemental2,2661,8531,345
Changes in working capital(40229)(18569)(21351)
Total cash from operations45,43358,87528,108
INVESTING
Capital expenditures(16403)(11323)(14660)
Other investing and cash flow items, total(23880)(30050)(11727)
Total cash from investing(40283)(41373)(26387)
FINANCING
Financing cash flow items(2266)(1853)(1345)
Total cash dividends paid(6648)(4979)(4146)
Issuance (retirement) of stock, net805368334
Issuance (retirement) of debt, net4,346(20397)2,735
Total cash from financing(3763)(26861)(2422)
NET CHANGE IN CASH
Foreign exchange effects(59)286733
Net change in cash1,328(9073)32
Net cash-begin balance/reserved for future use5,77914,85214,820
Net cash-end balance/reserved for future use7,1075,77914,852
SUPPLEMENTAL INCOME
Depreciation, supplemental14,84112,63611,824
Cash interest paid, supplemental2,2661,8531,345
Cash taxes paid, supplemental20,04710,7147,437
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.